Why Mario Alonso Built a Platform Instead of a Consumer Brand

Many entrepreneurs entering consumer products begin with the brand they want customers to recognize. Mario Alonso became interested in a different part of the equation: why promising technologies so often struggle to become products people actually use.

As Alonso studied advanced materials, he saw that scientific performance was only one part of commercialization. Manufacturers also had to determine whether a material could be produced consistently, added to existing production lines, and sold at a price customers would accept. A technology could work remarkably well in a lab and still fail commercially if adopting it required a manufacturer to rebuild a factory, disrupt its supply chain, or convince customers to change familiar habits.

That understanding shaped MN8 Innovative Solutions, the Miami-based company Alonso founded to develop proprietary materials that established manufacturers can incorporate into products they already know how to make. His experience may offer a useful lesson for entrepreneurs working with new technology: adoption may be easier when innovation fits with existing workflows and requires less disruption.

Make the new technology fit the existing behavior

Alonso’s interest in advanced materials developed after a serious illness led him to study the relationship between materials and human health. His research eventually brought him to far-infrared bioceramics, but he did not see the opportunity as simply creating one new wellness product.

He became interested in whether advanced materials could add functionality to products people already used. A shirt would still be worn like a shirt. A mattress would still fit into someone’s existing routine. The technological change could happen inside the product without requiring a corresponding change in consumer behavior.

MN8 now develops material technologies for applications including apparel, bedding, insoles, and recovery products. Instead of building retail brands around those products, it licenses the underlying technology to manufacturers with established production capabilities, distribution, and customer relationships.

Asking a manufacturer to adopt a new material was already a meaningful operational decision. Asking that company to redesign the product around it would create another reason to say no. Alonso therefore treated compatibility with existing products as part of the technology’s value rather than a problem to solve after the science was finished.

He compares the approach to Gore-Tex in a jacket or Intel in a computer. “We are not trying to be the brand on the shelf. We are trying to be the reason the product on the shelf works differently,” he says.

Evaluate innovation like an pperator

Although MN8 is built around scientific research, Alonso came to the company with experience building businesses in mobility, specialty finance, lending, and real estate. That background affected how he evaluated materials research because he was accustomed to looking beyond whether something could work.

A manufacturer considering a new material has to think about production costs, supplier relationships, quality standards, regulatory requirements, and the risk of disrupting existing operations. MN8 therefore has to develop materials that perform scientifically while remaining durable through repeated use, consistent across larger production runs, and valuable enough to justify their added cost.

That commercial filter also influences where the company chooses to expand. Performance apparel and recovery products may offer practical applications, as many consumers are already familiar with functional-material claims. Bedding and insoles offer another advantage because the materials remain in contact with the body for long periods.

MN8 has also considered applications such as cosmetics and wound care, but Alonso does not view every technically possible use as an immediate business opportunity. Different categories bring different testing, regulatory, and manufacturing demands. His approach is to let evidence and commercial readiness determine when an application is worth pursuing.

That discipline matters because technical possibility can easily outrun commercial readiness. The more useful question is whether a new application can be introduced reliably enough, and with little enough disruption, that another company has a practical reason to adopt it.

Build around the advantage you actually have

MN8’s licensing model also reflects a decision about where the company can contribute the most value. Rather than developing materials and then taking responsibility for branding, manufacturing, distribution, and retail sales, Alonso keeps the company focused on the underlying technology.

Manufacturing partners can apply the materials to categories they already understand while MN8 continues refining the science. That structure also gives established brands access to specialized research without requiring them to build internal materials teams, conduct years of experimentation, and develop the intellectual property themselves.

“The licensing model changes what growth looks like entirely,” Alonso says. “We are building a materials platform that manufacturers across multiple industries can plug into.”

The structure works because it aligns MN8’s role with the capability Alonso believes is hardest to reproduce. The company does not need to become the best apparel maker, bedding company, or recovery brand for its materials to reach those markets. It needs to keep developing technology that those businesses have a reason to incorporate.

That may leave MN8 less visible to consumers than the brands using its materials, but visibility is not the measure Alonso has chosen for the business. One potential opportunity is to build a platform that manufacturers may be able to adapt for multiple applications over time. For entrepreneurs deciding how much of a market they need to own, his approach offers a different way to think about growth: build around the part of the value chain where your advantage is strongest, and let other companies bring that advantage to customers.

This article is for informational purposes only and does not substitute for professional medical advice. If you are seeking medical advice, diagnosis or treatment, please consult a medical professional or healthcare provider.

Entrepreneur Media was not involved in the creation of this content.